<DOC>
	<DOCNO>NCT00110760</DOCNO>
	<brief_summary>Injection dermal filler use aesthetic treatment fill unwanted wrinkle scar . There substantial pain associate dermal filler injection . For reason , local anesthesia often used eliminate minimize pain . This anesthesia administer injection use topical cream ointment . S-Caine™ Peel ( lidocaine 7 % tetracaine 7 % cream ) eutectic formulation lidocaine tetracaine . The purpose study evaluate S-Caine Peel effective provide topical local dermal anesthesia dermal filler injection adult .</brief_summary>
	<brief_title>S-Caine™ Peel ( Skin Numbing Cream ) Treat Pain During Skin Filler Injection Face</brief_title>
	<detailed_description>This study randomize , double-blind , placebo control , pair study evaluate efficacy S-Caine Peel local dermal anesthesia facial dermal filler injection 70 adult . The study multi-center , 3 center participate . Patients present study center dermal filler injection procedure meet study entry criterion invite participate study . At screen visit , study , include potential risk benefit , clearly explain patient . A write date informed consent obtain patient . A medical history obtain include skin type , demographic data , use concomitant medication . A brief physical examination perform ( skin examination study treatment area basic vital sign ) , urine pregnancy test obtain female childbearing potential . At procedure visit , patient meet eligibility criterion assign low available sequential patient number . The randomization determine placement S-Caine Peel placebo active study drug apply either `` top/right '' `` bottom/left '' treatment area placebo apply alternate treatment area . The treatment area define 2 similar anatomical location require similar amount dermal filler ( measure mLs inject , number injection ) administer . The point reference designation patient 's right leave top bottom . Patients concurrent administration study drug , appropriate study drug apply top/right treatment area first follow immediately study drug apply bottom/left treatment area . Study drug application double-blind . The study drug apply uniform thickness approximately 1 mm remain skin 30 minute ( +/- 2 minute ) . Upon removal study drug ( top/right treatment area remove first , follow immediately removal study drug bottom/left treatment area ) , investigator evaluate treatment area erythema , edema , blanch adverse skin reaction .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Patient 18 year age old Patient elect undergo dermal filler injection face Patient pregnant breastfeeding Patient participate clinical trial unapproved drug within previous 30 day Patient participate previous clinical trial involve SCaine Peel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>